Controlled Clinical Trial of Dichloroacetate for Treatment of Congenital Lactic Acidosis in Children

Abstract

In this highly heterogeneous population of children with congenital lactic acidosis, oral DCA for 6 months was well tolerated and blunted the postprandial increase in circulating lactate. However, it did not improve neurologic or other measures of clinical outcome.